TrialHaematologica2015

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.

Jaap J Zwaginga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.